US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

33.16

-0.1125-0.34%

Post-market: 33.270.1125+0.34%16:10 EDT

Volume:201

Turnover:7K

Market Cap:24.04M

PE:- -

High:33.16

Open:33.31

Low:33.16

Close:33.27

52wk High:36.27

52wk Low:29.01

Shares:725.00K

Float Shares:725.00K

Volume Ratio:0.31

T/O Rate:0.03%

Dividend:0.76

Dividend Rate:2.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Palvella Therapeutics CEO to Speak at Cantor Global Healthcare Conference 2026

Zevra Therapeutics to Present at Cantor Global Healthcare Conference

Algoma Steel Resumes EAF Output Under Interim Power Plan After Lake Superior Outage

Edible Garden Regains NASDAQ $1 Minimum Bid Price Compliance

uniQure Seeks FDA Priority Review for Huntington’s Gene Therapy AMT-130 BLA

Lifecore Biomedical Signs Commercial Site Transfer Deal with Global Pharma Company

Kane Biotech Signs Non-Exclusive Canada Distribution Deal with Ontario Medical Supply

MediWound CEO Joins H.C. Wainwright Global Investment Conference Fireside Chat

Aeluma to Report Q4 and Full-Year Fiscal 2026 Results After Market Close, Host Conference Call

Cardiff Oncology to Present at RAS-Targeted Drug Development Summit

Verano Executive Team to Attend ATB Cormark Cannabis Institutional Investor Conference 2026

FactSet Schedules Q4 Fiscal 2026 Earnings Call

Rapport Therapeutics to Join Cantor Global Healthcare Conference Fireside Chat

Wallbridge Reports 52.3 G/t Gold over 2.1 Meters at Fenelon Metallurgical Drilling Program

TScan Therapeutics Cuts Workforce 75% in Reorganization to Focus on in Vivo Solid Tumor Cell Therapy

EyePoint to Join Citi, Cantor and Morgan Stanley Healthcare Investor Conferences

Sagimet Biosciences to Present at Cantor Global Healthcare Conference

Can-Fite Reports Longer-than-Expected Survival in Phase III Namodenoson Liver Cancer Trial

Opus Genetics to Report Phase 1/2 Cohort 1 Topline Data for OPGx-BEST1 Gene Therapy Sept. 9 Webcast

Fortrea to Buy Worldwide Clinical Trials Early-Phase Services Unit for $45M All-Cash

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BCDF/news?page=59"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","market":"US","secType":"STK","nameCN":"Horizon Kinetics Blockchain Development ETF","latestPrice":33.1605,"timestamp":1789156800000,"preClose":33.273,"halted":0,"volume":201,"hourTrading":{"tag":"盘后","latestPrice":33.273,"preClose":33.1605,"latestTime":"16:10 EDT","volume":4,"amount":132.642,"timestamp":1789157404304,"change":0.1125,"changeRate":0.003393,"amplitude":0},"delay":0,"changeRate":-0.0033811198268867927,"floatShares":725000,"shares":725000,"eps":0,"marketStatus":"Market Closed","change":-0.1125,"latestTime":"09-11 16:00:00 EDT","open":33.31,"high":33.1605,"low":33.1605,"amount":6704,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":33.273,"sharesOutstanding":675000,"nav":33.3,"aum":24142500,"dividendRate":0.022973,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.273,"preClose":33.1605,"latestTime":"16:10 EDT","volume":4,"amount":132.642,"timestamp":1789157404304,"change":0.1125,"changeRate":0.003393,"amplitude":0},"volumeRatio":0.31259719089899873},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","floatShares":725000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.31259719089899873,"shares":725000,"dividePrice":0.7618,"high":33.1605,"amplitude":0,"preClose":33.273,"low":33.1605,"week52Low":29.01,"pbRate":"--","week52High":36.27,"institutionHeld":0,"latestPrice":33.1605,"eps":0,"divideRate":0.022973,"volume":201,"delay":0,"ttmEps":0,"open":33.31,"prevYearClose":30.2172,"prevWeekClose":34.0101,"prevMonthClose":34.115,"prevQuarterClose":29.7995,"fiveDayClose":34.0114,"twentyDayClose":33.2426,"sixtyDayClose":31.5743},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDF\",params:#limit:5,,,undefined,":[{"date":"2024-12-24","symbol":"BCDF","amount":0.45302,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"Horizon Kinetics Blockchain Development ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"BCDF","amount":0.169967,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"market":"US","date":"2022-12-28","symbol":"BCDF","amount":0.05244,"defaultRemindTime":1672237800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2022-09-28","symbol":"BCDF","amount":0.0219,"defaultRemindTime":1664371800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-09-30","payableDate":"2022-09-29","currency":"USD","type":"dividend","dateTimestamp":1664337600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDF\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-28","recordDate":"2022-09-29","paymentDate":"2022-09-30","value":0.0219,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.05244,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.169967,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.45302,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCDF\",pageSize:20,pageCount:59,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664148816","title":"Palvella Therapeutics CEO to Speak at Cantor Global Healthcare Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664148816","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664148816?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348651,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics CEO to speak at Cantor Global Healthcare Conference 2026Palvella Therapeutics CEO Wes Kaupinen will join a fireside chat at the Cantor Global Healthcare Conference on Sept. 9, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLb3RZXc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","BK4588","NDAQ","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4585","PVLA","BK4139","SG9999014005.SGD","SG9999014021.USD","SG9999014013.SGD","LU0314104364.USD","LU2210149790.SGD","LU2095319765.USD","BK4112","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381614","title":"Zevra Therapeutics to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381614","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381614?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348645,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics to Present at Cantor Global Healthcare ConferenceZevra Therapeutics executives will present at investor conferences in New York on Sept. 9, Sept. 14, Sept. 15, 2026.Conference agend","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLgWBBB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BCDF","SG9999014013.SGD","SG9999014039.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","BK4588","SG9999014005.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","IE00BKPKM429.USD","BK4585","ZVRA","LU2095319765.USD","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","NDAQ","BK4007","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081619","title":"Algoma Steel Resumes EAF Output Under Interim Power Plan After Lake Superior Outage","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081619","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081619?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348622,"startTime":"0","endTime":"0","summary":"Algoma Steel resumes EAF output under interim power plan after Lake Superior outageAlgoma Steel resumed electric arc furnace production on Aug. 29 under interim power arrangements following an unplann","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbfMn8s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","IE00BKPKM429.USD","BK4006","BK4112","IE00B3QW5Z07.USD","ASTL","BK4585","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00B775SV38.USD","LU0314104364.USD","IE00B3S45H60.SGD","SG9999014021.USD","BCDF","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2210149790.SGD","BN","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","BK4135","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816605","title":"Edible Garden Regains NASDAQ $1 Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816605","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816605?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:28","pubTimestamp":1788348496,"startTime":"0","endTime":"0","summary":"Edible Garden regains Nasdaq $1 minimum bid price complianceEdible Garden AG regained compliance with Nasdaq’s $1 minimum bid price rule, removing a key delisting risk.Nasdaq confirmed the company now","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLMj3pp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","SG9999014013.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","IE00BQXX3C00.GBP","LU2210149790.SGD","EDBL","IE00B64PRP62.GBP","BCDF","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4585","IE00BQXX3F31.USD","BK4588","BK4112","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815263","title":"uniQure Seeks FDA Priority Review for Huntington’s Gene Therapy AMT-130 BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815263","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815263?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:06","pubTimestamp":1788347200,"startTime":"0","endTime":"0","summary":"uniQure seeks FDA priority review for Huntington’s gene therapy AMT-130 BLAuniQure filed a Biologics License Application with the FDA seeking accelerated approval of AMT-130 for Huntington’s disease.T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9GzjZl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU0320765992.SGD","IE00BQXX3D17.EUR","LU0314104364.USD","LU0889565916.HKD","LU2210149790.SGD","BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BKPKM429.USD","SG9999014005.SGD","NDAQ","SG9999014039.USD","BK4139","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","BK4112","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4588","BK4585","IE00BN0W2W23.USD","SG9999014021.USD","LU0109394709.USD","QURE","SG9999014013.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815257","title":"Lifecore Biomedical Signs Commercial Site Transfer Deal with Global Pharma Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815257","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815257?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:06","pubTimestamp":1788347198,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical signs commercial site transfer deal with global pharma companyLifecore Biomedical signed an agreement to transfer a commercially marketed injectable drug product into its pipeline ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL1MDFX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014013.SGD","BK4121","IE00BQXX3D17.EUR","BK4112","IE00B64PRP62.GBP","BCDF","BK4212","LFCR","NDAQ","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU2095319765.USD","LU0314104364.USD","BK4585","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014021.USD","LU2210150020.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881528","title":"Kane Biotech Signs Non-Exclusive Canada Distribution Deal with Ontario Medical Supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881528","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881528?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347141,"startTime":"0","endTime":"0","summary":"Kane Biotech signs non-exclusive Canada distribution deal with Ontario Medical SupplyKane Biotech entered a non-exclusive Canadian distribution agreement with Ontario Medical Supply, expanding commerc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL48fvbt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BCDF","LU0314104364.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014005.SGD","BK4112","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","SG9999014013.SGD","LU2095319765.USD","NDAQ","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","BK4588","IE00BQXX3F31.USD","IE00BGHQF748.EUR","BK4585","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815125","title":"MediWound CEO Joins H.C. Wainwright Global Investment Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815125","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815125?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346966,"startTime":"0","endTime":"0","summary":"MediWound CEO joins H.C. Wainwright Global Investment Conference fireside chatMediWound will participate in the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New Yo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5xvK0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","NDAQ","IE00BN0W2T93.GBP","LU2095319765.USD","BK4588","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","MDWD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","BK4585","BCDF","SG9999014039.USD","IE00BQXX3F31.USD","BK4112","IE00BQXX3D17.EUR","SG9999014005.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664581514","title":"Aeluma to Report Q4 and Full-Year Fiscal 2026 Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664581514","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664581514?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346949,"startTime":"0","endTime":"0","summary":"Aeluma to report Q4 and full-year fiscal 2026 results after market close, host conference callAeluma schedules Q4 and full-year fiscal 2026 results release for Sept. 16, 2026, following the U.S. marke","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL6Px4DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","SG9999014005.SGD","BK4147","BK4585","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NDAQ","BK4112","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","ALMU","LU0314104364.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BKPKM429.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4588","IE00B3QW5Z07.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664181510","title":"Cardiff Oncology to Present at RAS-Targeted Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664181510","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664181510?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346949,"startTime":"0","endTime":"0","summary":"Cardiff Oncology to present at RAS-targeted drug development summitCardiff Oncology will present at the 8th Annual RAS-Targeted Drug Development Summit on Sept. 8 at 9:00 a.m. ET.Mani Mohindru will jo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL8bcNWY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BQXX3C00.GBP","LU0314104364.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4585","IE00B64PRP62.GBP","BK4139","CRDF","LU2210149790.SGD","SG9999014005.SGD","BCDF","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815106","title":"Verano Executive Team to Attend ATB Cormark Cannabis Institutional Investor Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815106","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815106?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346947,"startTime":"0","endTime":"0","summary":"Verano executive team to attend ATB Cormark Cannabis Institutional Investor Conference 2026Verano will attend the ATB Cormark Cannabis Institutional Investor Conference 2026 on Sept. 9, 2026, in New Y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL1R5jKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","BCDF","LU0314104364.USD","LU2210150020.SGD","BK4585","SG9999014021.USD","SG9999014013.SGD","BK4112","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4588","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","NDAQ","LU2095319765.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664151708","title":"FactSet Schedules Q4 Fiscal 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664151708","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664151708?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346945,"startTime":"0","endTime":"0","summary":"FactSet schedules Q4 fiscal 2026 earnings callFactSet schedules fourth-quarter fiscal 2026 results release for Sept. 30, 2026.Earnings conference call set for 9:00 a.m. ET on Sept. 30, 2026, followed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9TCdTr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3C00.GBP","SG9999014005.SGD","BK4585","BK4112","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4567","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","BCDF","SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","FDS","LU2210149790.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664142815","title":"Rapport Therapeutics to Join Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664142815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664142815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346945,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics to Join Cantor Global Healthcare Conference Fireside ChatRapport Therapeutics will join the Cantor Global Healthcare Conference in New York City on Sept. 9, 2026.Management will a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbWhh7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4112","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014021.USD","SG9999014005.SGD","IE00BQXX3F31.USD","RAPP","NDAQ","SG9999014039.USD","IE00BGHQF748.EUR","BCDF","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","BK4007","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664109815","title":"Wallbridge Reports 52.3 G/t Gold over 2.1 Meters at Fenelon Metallurgical Drilling Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2664109815","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664109815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346937,"startTime":"0","endTime":"0","summary":"Wallbridge reports 52.3 g/t gold over 2.1 meters at Fenelon metallurgical drilling programWallbridge reported final assays from seven 2026 metallurgical drill holes at its Fenelon Gold Project, suppor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLblMRbR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","IE00BKPKM429.USD","LU2210149790.SGD","LU0314104364.USD","BK4588","IE00B64PRP62.GBP","BCDF","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4112","IE00BN0W2T93.GBP","SG9999014039.USD","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4585","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664481517","title":"TScan Therapeutics Cuts Workforce 75% in Reorganization to Focus on in Vivo Solid Tumor Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664481517","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664481517?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346932,"startTime":"0","endTime":"0","summary":"TScan Therapeutics cuts workforce 75% in reorganization to focus on in vivo solid tumor cell therapyTScan Therapeutics launched a strategic reorganization to prioritize in vivo TCR-T cell therapy for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7rnZG4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4139","IE00B3QW5Z07.USD","BK4585","IE00BQXX3F31.USD","SG9999014021.USD","IE00BGHQF748.EUR","BCDF","BK4112","IE00BQXX3D17.EUR","IE00BKPKM429.USD","BK4539","NDAQ","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00BN0W2V16.EUR","TCRX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815104","title":"EyePoint to Join Citi, Cantor and Morgan Stanley Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815104","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815104?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346928,"startTime":"0","endTime":"0","summary":"EyePoint to join Citi, Cantor and Morgan Stanley healthcare investor conferencesEyePoint will join investor fireside chats at Citi’s Biopharma Back to School Conference on Sept. 9, 2026, 8:00 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL4z4HqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00BN0W2W23.USD","LU1244550221.USD","IE00BQXX3D17.EUR","LU0052756011.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2324357040.USD","LU0106831901.USD","LU0072461881.USD","LU2095319765.USD","LU2125154778.USD","LU2417539215.USD","IE00BSNM7G36.USD","IE00BQXX3F31.USD","LU0889565916.HKD","LU2210150020.SGD","NDAQ","BK4566","FTXO","LU1244550494.USD","LU0098860793.USD","BK4559","LU0477156953.USD","LU1366192091.USD","LU1244550577.SGD","LU2210149790.SGD","IYF","LU1144417596.USD","LU0980610538.SGD","BCDF","EYPT","BK4534","LU0170899867.USD","LU2456880835.USD","LU1267930227.SGD","LU2462157665.USD","LU0130102774.USD","IE00BKPKM429.USD","LU1162221912.USD","LU0314104364.USD","TFNS","SG9999014021.USD","IE00BN0W2V16.EUR","BK4007","LU0310800965.SGD","LU1506573853.SGD","SG9999014013.SGD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815971","title":"Sagimet Biosciences to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815971","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815971?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:01","pubTimestamp":1788346907,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences to present at Cantor Global Healthcare ConferenceSagimet management scheduled to attend the Cantor 2026 Global Healthcare Conference in New York on Sept. 9, 2026.Fireside chat set ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5DfZm3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3C00.GBP","SG9999014005.SGD","BK4585","BK4112","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","BCDF","SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","SGMT","LU2210149790.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","BK4139","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664974815","title":"Can-Fite Reports Longer-than-Expected Survival in Phase III Namodenoson Liver Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664974815","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664974815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:01","pubTimestamp":1788346885,"startTime":"0","endTime":"0","summary":"Can-Fite reports longer-than-expected survival in Phase III Namodenoson liver cancer trialCan-Fite flagged longer-than-anticipated overall survival in its ongoing pivotal Phase III Namodenoson trial i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL4JfqRr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","IE00BKPKM429.USD","BCDF","BK4585","IE00BQXX3C00.GBP","BK4112","LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","IE00BQXX3D17.EUR","SG9999014005.SGD","SG9999014039.USD","NDAQ","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815949","title":"Opus Genetics to Report Phase 1/2 Cohort 1 Topline Data for OPGx-BEST1 Gene Therapy Sept. 9 Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815949","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815949?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:01","pubTimestamp":1788346876,"startTime":"0","endTime":"0","summary":"Opus Genetics to report Phase 1/2 Cohort 1 topline data for OPGx-BEST1 gene therapy Sept. 9 webcastOpus Genetics set a Sept. 9, 2026 investor webcast to present topline Phase 1/2 Cohort 1 data for OPG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL2m3155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BGHQF748.EUR","BCDF","IRD","BK4112","SG9999014005.SGD","BK4588","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","SG9999014021.USD","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","BK4139","LU2095319765.USD","BK4585","NDAQ","IE00BN0W2T93.GBP","LU2210149790.SGD","BK4007","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281560","title":"Fortrea to Buy Worldwide Clinical Trials Early-Phase Services Unit for $45M All-Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281560","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281560?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346857,"startTime":"0","endTime":"0","summary":"Fortrea to buy Worldwide Clinical Trials early-phase services unit for $45M all-cashFortrea agreed to buy Worldwide Clinical Trials’ Early Phase Services division in an all-cash deal valued at about U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL95qRHR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4121","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","LU2210150020.SGD","BK4585","NDAQ","BK4588","IE00BKPKM429.USD","LU2095319765.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","BCDF","BK4112","IE00B64PRP62.GBP","IE00BQXX3D17.EUR","SG9999014039.USD","FTRE","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":78,"pageCount":59,"totalSize":1551,"code":"91000000","status":"200"}]}}